PortfoliosLab logo
SGMT vs. YMAB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SGMT and YMAB is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

SGMT vs. YMAB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sagimet Biosciences Inc. (SGMT) and Y-mAbs Therapeutics, Inc. (YMAB). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

SGMT:

84.23%

YMAB:

90.85%

Max Drawdown

SGMT:

-10.86%

YMAB:

-9.18%

Current Drawdown

SGMT:

-9.19%

YMAB:

-8.47%

Fundamentals

Market Cap

SGMT:

$104.96M

YMAB:

$176.13M

EPS

SGMT:

-$1.45

YMAB:

-$0.67

PS Ratio

SGMT:

52.50

YMAB:

2.01

PB Ratio

SGMT:

0.67

YMAB:

1.91

Total Revenue (TTM)

SGMT:

$0.00

YMAB:

$94.25M

EBITDA (TTM)

SGMT:

-$45.69M

YMAB:

-$29.85M

Returns By Period


SGMT

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

YMAB

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SGMT vs. YMAB — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SGMT
The Risk-Adjusted Performance Rank of SGMT is 4141
Overall Rank
The Sharpe Ratio Rank of SGMT is 3838
Sharpe Ratio Rank
The Sortino Ratio Rank of SGMT is 5050
Sortino Ratio Rank
The Omega Ratio Rank of SGMT is 4848
Omega Ratio Rank
The Calmar Ratio Rank of SGMT is 3434
Calmar Ratio Rank
The Martin Ratio Rank of SGMT is 3737
Martin Ratio Rank

YMAB
The Risk-Adjusted Performance Rank of YMAB is 22
Overall Rank
The Sharpe Ratio Rank of YMAB is 33
Sharpe Ratio Rank
The Sortino Ratio Rank of YMAB is 11
Sortino Ratio Rank
The Omega Ratio Rank of YMAB is 33
Omega Ratio Rank
The Calmar Ratio Rank of YMAB is 44
Calmar Ratio Rank
The Martin Ratio Rank of YMAB is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SGMT vs. YMAB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sagimet Biosciences Inc. (SGMT) and Y-mAbs Therapeutics, Inc. (YMAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

SGMT vs. YMAB - Dividend Comparison

Neither SGMT nor YMAB has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

SGMT vs. YMAB - Drawdown Comparison

The maximum SGMT drawdown since its inception was -10.86%, which is greater than YMAB's maximum drawdown of -9.18%. Use the drawdown chart below to compare losses from any high point for SGMT and YMAB. For additional features, visit the drawdowns tool.


Loading data...

Volatility

SGMT vs. YMAB - Volatility Comparison


Loading data...

Financials

SGMT vs. YMAB - Financials Comparison

This section allows you to compare key financial metrics between Sagimet Biosciences Inc. and Y-mAbs Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00M30.00M35.00M202120222023202420250
26.50M
(SGMT) Total Revenue
(YMAB) Total Revenue
Values in USD except per share items